University of Louisville Infectious Diseases COVID-19 Biobank
Disease of Interest: COVID-19
Principle Investigator: Subathra Marimuthu, PhD
The Infectious Diseases Biorepository has expanded to include high quality human specimens and data support for investigator research in the development of novel diagnostic and therapeutics for COVID-19. The COVID-19 Biobank offers prospective and retrospective specimen selection from the bank of whole blood, serum, plasma, urine, sputum, bronchioalveolar, and tissue samples from subjects hospitalized and test-positive for COVID-19. All COVID-19 Biobank samples are connected to clinical data. The table below lists what is currently possible through our COVID-19 Biobank.
Currently, the COVID-19 Biobank contains samples from ____ unique patients.
COVID-19 Specimen Selection